TransEnterix invests $ 33 million in medical surgery technologies
TransEnterix (NYSE: TRXC) announced yesterday that it has agreed to acquire Medical Surgery Technologies and its surgical planning technology in a two-step deal valued at nearly $ 33 million. MST,…
How our body clock could dictate medical treatments
This is where the going gets tough. Technically speaking, TimeSignature guesses when a subject’s blood has been collected—not the subject’s circadian state at the time of sampling. Because these samples…